|
||
|
Selected Publications
BL Rodriguez, X Li, K Kiguchi, J DiGiovanni, EC Unger, Z Cui, Control of solid tumor growth in mice using EGF receptor targeted RNA replicase-based plasmid DNA. Nanomedicine (UK) (2011), In press. BR Sloat, K Kiguchi, G Xiao, J DiGiovanni, W Maury, Z Cui, Transcutaneous DNA immunization following waxing-based hair depilation. J. Control. Release (2011), in press. MA Sandoval, BR Sloat, DSP Lansakara-P., A Kumar, BL Rodriguez, K Kiguchi, J DiGiovanni, Z Cui, EGFR-targeted stearoyl gemcitabine nanoparticles show enhanced anti-tumor activity. J. Control. Release (2011), doi:10.1016/j.jconrel.2011.08.015. WG Chung, BR Sloat, MA Sandoval, DSP Lansakara-P., Z Cui, Stearoyl gemcitabine nanoparticles overcome resistance related to the over-expression of ribonucleotide reductase M1. J. Control. Release (2011), doi:10.1016/j.jconrel.2011.08.004. N Yanasarn, BR Sloat, Z Cui, Negatively charged liposomes show strong adjuvant activity when simply admixed with protein antigens. Molecular Pharmaceutics (2011) 8(4):1174-85. A Kumar, X Li, MA Sandoval, BL Rodriguez, BR Sloat, Z Cui, Permeation of antigen protein conjugated nanoparticles and live bacteria through microneedle-treated mouse skin. Int. J. Nanomedicine (2011) 6:1253-1264. BR Sloat, MA Sandoval, D Li, WG Chung, DSP Lansakara-P., PJ Proteau, K Kiguchi, J DiGiovanni, Z Cui, In vitro and in vivo anti-tumor activity of a gemcitabine derivative carried by nanoparticles. Int. J. Pharm. (2011) 409:278-288. BL Rodriguez, Z Yu, WG Chung, R Weiss, Z Cui, RNA replicase-based plasmid DNA shows anti-tumor activity. BMC Cancer (2011) 11:110 (highly accessed). X Li, BR Sloat, N Yanasarn, Z Cui, Relationship between the size of nanoparticles and their adjuvant activity: Data from a study with an improved experimental design. Eur. J. Pharm. Biopharm. (2011) 78:107-116. BR Sloat, MA Sandoval, AM Hau AM, Y He Y, Z Cui. Strong antibody responses induced by protein antigens conjugated onto the surface of lecithin-based nanoparticles. J. Control. Release (2010) 141(1): 93-100. UM Le, DML Kaurin, BR Sloat, N Yanasarn, Z Cui, Localized irradiation of tumors prior to a dsRNA therapy significantly enhanced the resultant anti-tumor activity. Radiother. Oncol. (2009) 90(2):273-9. UM Le, N Yanasarn, CV Lӧhr, K Fischer, Z Cui. Tumor chemo-immunotherapy using gemcitabine and a synthetic dsRNA. Cancer Biol. Ther. (2008) 7(3):440-7. DS Shaker, BR Sloat, UM Le, N Yanasarn, KA Fischer, CV Lӧhr, Z Cui. Immunization by applying DNA vaccine onto a skin area wherein the hair follicles have been induced into anagen-onset stage. Mol. Ther. (2007) 15(11): 2037-43. BR Sloat, Z Cui. Nasal immunization with a dual antigen anthrax vaccine induced strong mucosal and systemic immune responses against toxins and bacilli. Vaccine (2006) 24(40-41):6405-13. Z Cui, PR Lockman, CS Atwoord, CH Hsu, A Gupte, DD Allen, RJ Mumper. Novel D-penicillamine carrying nanoparticles for metal chelation therapy of Alzheimer's and other CNS diseases. Eur. J. Pharm. Biopharm. (2005) 59(2):263-272. Z Cui, J Patel, M Tuzova, P Ray, R Phillips, JG Woodward, A Nath, RJ Mumper. Strong T cell type 1 immune responses to HIV-1 Tat protein-coated nanoparticles. Vaccine (2004) 22(20):2631-40. Z Cui, RJ Mumper. Buccal delivery of salmon calcitonin in rabbits using novel bi-layer mucoadhesive films. Pharm. Res. (2003) 19(12):1901-6. Z Cui and RJ Mumper. Topical immunization using nanoengineered genetic vaccines. J. Control. Release (2002) 81:173-184. Z Cui and RJ Mumper. Chitosan-based nanoparticles for topical genetic immunization. J. Control. Release (2001) 75(3):409-419. For a complete list of publications, please search on www.pubmed.gov. |
||
Division Information
Mailing Address:
Pharmaceutics Division
College of Pharmacy
The University of Texas
at Austin
1 University Station,
A1900
Austin, TX
78712-01200
USA
Email Address: pharmacy
@www.utexas.edu
Phone:
1-512-471-7182
Enhancing drug-delivery technologies can help in curing and treating diseases such as cancer, cardiovascular diseases, diabetes, fungal, respiratory and infectious diseases and treatment after organ transplants to prevent rejection.
Justin Hughey, graduate student of Dr. James McGinity, has been awarded a graduate student scholarship by the International Pharmaceutical Excipients Council of the Americas Foundation.